Volume 5, Issue 2 (Summer 2001)                   2001, 5(2): 12-16 | Back to browse issues page

XML Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Jaffri H, Vaez Mahdavi M, Gharebaghi R. Effect of ICWS and TENS on reduction of withrawal syndrome signs in rat. Journal of Inflammatory Diseases. 2001; 5 (2) :12-16
URL: http://journal.qums.ac.ir/article-1-487-en.html
Abstract:   (13790 Views)
Background: Drug addiction is a destructive misfortune that leads to recession in all fields. Accordingly, proper treatment of addiction is of great importance. Objective: To evaluate the efficiency of TENS and ICWS on reduction of withdrawal syndrome signs of morphine. Methods: Four groups of Spruge-Dawley type rats were depended with morphine subcutaneously in a standard condition. After dependency, the first group was considered as the control, the second and third group were affected with high frequency of TENS and ICWS respectively and the forth group was affected by ICWS and TENS together. In all groups naloxone was injected in the peritoneum and the withdrawal syndrome signs of morphine were studied. Statistical analysis were done by ANOVA, LSD, Kruskal-Walis and Mann-Whitney. Findings: TENS was very effective in reduction of jumping and climbing and also ICWS was very effective in reduction of petosis and rearing (P<0.05). The interacted effect of TENS and ICWS did not reduce some of the signs for example jumping, rearing, petosis and climbing. On the contrary, diarrhea, weight loss, yamning, abnormal posture and facial fasciculation were reducted significantly. Conclusion: The interacted effect of TENS & ICWS reduced only few signs and each method could reduce the signs separately. More studies on human mechanism is suggested.
Full-Text [PDF 783 kb]   (2113 Downloads)    
Type of Study: Research | Subject: Physiology

Add your comments about this article : Your username or Email:

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2023 CC BY-NC 4.0 | Journal of Inflammatory Diseases

Designed & Developed by : Yektaweb